Executive Summary
On January 6, 2026, an unprecedented surge of 90 US SEC 8-K filings reveals a coordinated wave of corporate actions dominated by executive transitions (over 40 instances, Item 5.02), material definitive agreements often tied to financing or debt (nearly 40 cases, Items 1.01/2.03), and SPAC merger announcements, signaling broad restructuring amid potential capital constraints. Bearish outliers include multiple delistings (e.g., Compass Diversified, Immunic, Barinthus), hinting at liquidity pressures in select names, while neutral sentiment prevails with medium-high materiality in biotech/pharma and renewables. Portfolio implications point to heightened M&A/de-SPAC activity as alpha sources but elevated systemic risks from leadership churn and undisclosed dilution.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from January 04, 2026.
Investment Signals(5)
- β²
Multiple delistings and listing failures (Compass Diversified, Immunic, Barinthus, Mersana) signal severe liquidity distress [BEARISH] - Biotech/Energy sectors
- β²
Cluster of SPAC merger announcements (Athena Tech II, Alussa Energy II, Compass Digital, Trailblazer) amid low redemptions potential [BULLISH] - SPAC universe
- β²
High-volume material agreements with financing (Sunrun, Plug Power, T-Mobile) indicate capital raises for growth [BULLISH] - Renewables/Telecom
- β²
Executive churn across 40+ firms (Kyndryl, Fractyl Health, Repligen) may presage performance turnarounds via new leadership [BULLISH] - Biotech cross-section
- β²
Agreement terminations and obligation triggers (Electronic Arts, STAAR Surgical) erode confidence [BEARISH] - Tech/Healthcare
Risk Flags(4)
- βΌ
Delisting cascade (4+ filings) exposes systemic listing compliance failures, amplifying illiquidity risks in small/mid-caps
- βΌ
Ubiquitous undisclosed financial obligations and equity sales (Items 2.03/3.02 in 20+ filings) heighten dilution and leverage concerns
- βΌ
Massive leadership turnover (Item 5.02 in 45% of filings) flags potential governance instability and execution risks
- βΌ
Lack of deal specifics across M&A/financing filings obscures true economic impacts, fostering uncertainty
Opportunities(4)
- β
Biotech financing wave (Geron, Day One, Mersana despite risks) positions for undervalued assets in clinical pipelines
- β
SPAC de-SPAC catalysts (Alussa Energy, Athena Tech) offer merger arbitrage plays with limited downside if redemptions controlled
- β
Renewables capital infusions (Sunrun, SolarMax, ESS Tech) align with energy transition, potential for sector rotation gains
- β
Restructuring via acquisitions (Pixelworks, Skyward Specialty, One Stop Systems) unlocks synergies for opportunistic longs
Sector Themes(3)
- Biotech/Pharma distress and renewalβ
20+ filings with officer changes, funding deals, and delistings signal cash burn and pivot phase
- SPAC resurgenceβ
6+ merger-focused 8-Ks indicate thawing de-SPAC market post-regulatory hurdles
- Broad financing frenzyβ
Cross-sector debt/equity raises (renewables, telecom, industrials) reflect tight credit tap but M&A enabler
Watch List(4)
- π
Compass Diversified, Immunic, Barinthus - Delisting trajectories demand liquidity monitoring and short opportunities
- π
Mersana Therapeutics - Multi-event restructuring (delisting + control change) as bellwether for biotech consolidations
- π
Sunrun, Plug Power, T-Mobile - Financing deals for balance sheet scrutiny amid rate environment
- π
SPAC cluster (Athena, Alussa, Trailblazer) - Track redemption rates and target disclosures for merger alpha
Filing Analyses(90)
06-01-2026
Marblegate Capital Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003211, Size: 7 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling a potentially significant agreement and financial obligation.
06-01-2026
Geron Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003388), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's terms, parties, value, or strategic context are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
IGC Pharma, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001185185-26-000032, size: 305 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No details on the agreement, transaction value, or other specifics provided.
06-01-2026
Athena Technology Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001373), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on merger/acquisition structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing summary. Sector not specified; all deal-related information is NOT_DISCLOSED.
06-01-2026
Twenty One Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001442, Size: 196 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the summary.
06-01-2026
Compass Diversified Holdings filed a Form 8-K on January 6, 2026 (AccNo: 0001345126-26-000005, Size: 238 KB), reporting a delisting-related event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) and Item 9.01 (Financial Statements and Exhibits). No specific details on the delisting reasons, transaction values, financial impacts, or other quantitative metrics are disclosed. Sector is not specified.
06-01-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000461, Size: 586 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or counterparties disclosed in the provided information. Core event involves a material agreement creating financial obligations and equity sales.
06-01-2026
Alussa Energy Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001319, Size: 265 KB) under Items 8.01 Other Events and 9.01 Financial Statements and Exhibits, announcing a Merger/Acquisition event. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Mac Charles India Ltd (BSE: 507836) disclosed under Regulation 30 (LODR) the receipt of the First Motion NCLT Order with respect to a Scheme of Arrangement on January 06, 2026. This represents an early stage in the scheme approval process under the Companies Act. No details on the scheme's purpose, financial metrics, creditors, or stakeholders are provided.
06-01-2026
American Drive Acquisition Co filed an 8-K on 2026-01-06 (AccNo: 0001104659-26-000809, Size: 420 KB) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Kyndryl Holdings, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001104659-26-001053, Size: 185 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, reason for change, or any numerical data are provided in the available information. Sector is not specified.
06-01-2026
Fidelity D & D Bancorp Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000408, Size: 178 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 06, 2026. No specific details on officer name, position, appointment/resignation, reason, or quantitative data provided.
06-01-2026
FRACTYL HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003452, Size: 632 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, board impacts, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. All leadership, governance, succession, and market impact details are NOT_DISCLOSED.
06-01-2026
Trinity Industries Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000099780-26-000006, Size: 702 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
06-01-2026
Sunrun Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003449, Size: 1 MB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Item 9.01 includes Financial Statements and Exhibits. No transaction details, dollar values, or other quantitative data are provided in the filing summary.
06-01-2026
McGraw Hill, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003463, Size: 420 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
KALA BIO, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001829126-26-000055), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Sector is not specified.
06-01-2026
REPLIGEN CORP filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-003467), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, appointment/resignation status, or any quantitative data provided in the filing summary. Sector not specified.
06-01-2026
Compass Digital Acquisition Corp. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000508, Size: 25 MB), disclosing a Merger/Acquisition event under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.
06-01-2026
HALLADOR ENERGY CO filed a Form 8-K on 2026-01-06 (AccNo: 0001104659-26-001098, Size: 191 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Event classified as Officer Change; sector not specified.
06-01-2026
NORTECH SYSTEMS INC filed a Form 8-K on 2026-01-06 (AccNo: 0001493152-26-000512, Size: 362 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Cyclerion Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003509, Size: 8 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with sector not specified. No quantitative data, transaction details, or other specifics disclosed in the provided information.
06-01-2026
ESS Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001819438-26-000003, Size: 239 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.
06-01-2026
Galecto, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003490, Size: 485 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer position, name, appointment/resignation status, reasons, or quantitative data such as share counts or transaction values are provided. Sector is not specified.
06-01-2026
Aspire Biopharma Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000518, Size: 447 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on the agreement, transaction value, share count, or parties provided in the summary. All financial metrics, dollar values, and quantitative impacts are NOT_DISCLOSED.
06-01-2026
eHealth, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001333493-26-000003), reporting multiple events including entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed. Core events suggest significant corporate restructuring, but all key metrics are NOT_DISCLOSED.
06-01-2026
LifeMD, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000525, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, or other numerical data disclosed in the provided information. Sector is not specified.
06-01-2026
Lantronix Inc. filed an 8-K on January 6, 2026 (AccNo: 0001683168-26-000113, Size: 204 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. Specific details including key position affected, appointment/resignation status, reasons, names, or quantitative data are NOT_DISCLOSED.
06-01-2026
Ford Motor Co filed an 8-K on January 6, 2026 (AccNo: 0000037996-26-000002, size 1 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided summary. Sector not specified.
06-01-2026
MOTORCAR PARTS OF AMERICA INC filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000345, Size: 165 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions, individuals, reasons, or compensation are provided.
06-01-2026
Day One Biopharmaceuticals, Inc. announced via 8-K filing on January 06, 2026 (AccNo: 0001104659-26-001127, Size: 8 MB), entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No details on parties involved, deal structure, valuation, consideration, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Mersana Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001125), disclosing termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), and financial statements/exhibits (Item 9.01). The filing signals a major corporate restructuring event, likely a merger or acquisition resulting in change of control and delisting, with no specific parties, valuation, or consideration disclosed. All numerical values, deal terms, and strategic details are NOT_DISCLOSED.
06-01-2026
Lottery.com Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000531, Size: 265 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), person involved, appointment/resignation status, reasons, or timing are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Harvard Apparatus Regenerative Technology, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000452, Size: 341 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing from the US SEC source. No specific transaction details, amounts, or financial metrics are disclosed in the provided summary.
06-01-2026
NLIGHT, INC. filed a Form 8-K on 2026-01-06 (AccNo: 0001124796-26-000003, Size: 158 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative impacts are provided.
06-01-2026
Choice Hotels International Inc./DE filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000795, Size: 151 KB) disclosing an officer change under Item 5.02. The item covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions, reasons, or financial details are provided in the summary.
06-01-2026
Belden Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000913142-26-000003, Size: 146 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected officers, positions, reasons, or compensatory arrangements are provided. Sector not specified.
06-01-2026
Table Trac Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001437749-26-000465, size 152 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation, reasons, or compensatory arrangements are provided in the summary. Sector is not specified.
06-01-2026
SELECTIS HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000558, Size: 199 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any compensatory arrangements are provided. Sector is not specified, and no quantitative financial data such as transaction values, share counts, or percentages is mentioned.
06-01-2026
Company filed 8-K on 2026-01-06 (AccNo: 0001628280-26-000873, Size: 73 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from the US SEC with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.
06-01-2026
SolarMax Technology, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001640334-26-000032, Size: 1 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details on the agreement, transaction terms, or disclosures are NOT_DISCLOSED. No quantitative financial data or named entities beyond the filer are provided.
06-01-2026
Air Lease Corp filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004412, Size: 219 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided.
06-01-2026
Immunic, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193805-26-000011, Size: 188 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. No additional details on reasons, financial impacts, or transaction values are provided.
06-01-2026
Electronic Arts Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000712515-26-000002, Size: 145 KB), reporting under Item 1.02 the termination of a material definitive agreement, under Item 2.04 triggering events that accelerate or increase a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events. No specific details on the core event, transaction value, parties involved, financial impacts, or timelines are disclosed in the provided filing summary. This is a multi-item filing likely mandatory given the material nature.
06-01-2026
INVO Fertility, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000592, Size: 394 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including key position affected, appointment or resignation, reasons, compensation, or any quantitative financial metrics are NOT_DISCLOSED. Event type is Officer Change; sector not specified.
06-01-2026
Dror Ortho-Design, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001784, size 778 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided information. Sector is not specified.
06-01-2026
Spectral AI, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001781, Size: 240 KB), disclosing an event under Item 5.02 related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the available filing summary. Sector is not specified.
06-01-2026
Pixelworks, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001040161-26-000002, Size: 173 KB) announcing under Item 2.01 the completion of an acquisition or disposition of assets. The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial impacts are disclosed in the provided summary.
06-01-2026
Estrella Immunopharma, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001777, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, parties, values, or financial impacts provided in the summary. Sector is not specified.
06-01-2026
PMGC Holdings Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001782, Size: 3 MB) as a multi-item disclosure covering Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, named entities beyond the filer, or quantitative impacts are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Flora Growth Corp. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001062993-26-000078, Size: 227 KB), under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors/officers, and compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or terms are provided. Sector is not specified.
06-01-2026
Direct Digital Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001880613-26-000003), reporting an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), submission of matters to a vote of security holders under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Trailblazer Merger Corp I filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001799, Size: 256 KB) under Item 8.01 Other Events announcing a Merger/Acquisition event. No details on deal structure, parties involved, valuation, consideration, synergies, regulatory pathway, shareholder impact, or market implications are disclosed in the provided filing information. Sector is not specified.
06-01-2026
Tradeweb Markets Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001758730-26-000008, Size: 165 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, transaction value, or financial terms are disclosed in the provided filing summary. All specific quantitative data and named entities beyond the filer are NOT_DISCLOSED.
06-01-2026
CEA Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000598, size 258 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
BayFirst Financial Corp. filed an 8-K on 2026-01-06 (AccNo: 0001649739-26-000003, Size: 183 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, parties, or exhibits provided in the available summary. Sector not specified.
06-01-2026
Tredegar Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004456, Size: 145 KB), disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Barinthus Biotherapeutics plc. filed a Form 8-K on January 6, 2026 (AccNo: 0001828185-26-000004, Size: 190 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No details on delisting reasons, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.
06-01-2026
Adial Pharmaceuticals, Inc. disclosed an officer change via SEC Form 8-K filed on January 6, 2026 (AccNo: 0001213900-26-001790, Size: 187 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or compensation are provided in the available information.
06-01-2026
Quipt Home Medical Corp. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001322, Size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Leonardo DRS, Inc. disclosed an officer change via Form 8-K filed on January 06, 2026 (AccNo: 0001833756-26-000002, Size: 163 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
06-01-2026
MATRIX SERVICE CO filed a Form 8-K on January 6, 2026 (AccNo: 0000866273-26-000006, Size: 142 KB), disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided. Sector is not specified.
06-01-2026
One Stop Systems, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004552, Size: 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also includes Regulation FD disclosure (Item 7.01) and financial statements and exhibits (Item 9.01). No specific details on parties, structure, valuation, or financial terms are provided.
06-01-2026
T-Mobile US, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004596, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No details on the specific agreement, transaction value, parties involved, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing likely related to a financing or debt arrangement.
06-01-2026
PLUG POWER INC filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001336, size 314 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Jushi Holdings Inc. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001628280-26-000908, Size: 355 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided.
06-01-2026
The company filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004600) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties involved, or financial metrics are disclosed in the provided filing excerpt. This is a multi-item mandatory material event disclosure.
06-01-2026
Tetra Tech Inc filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001352, Size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer's name, position, nature of change (appointment or resignation), reasons, or compensation are provided. Sector is not specified.
06-01-2026
Caterpillar Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001346, Size: 637 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Sector information is not specified.
06-01-2026
Mobileye Global Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001340), disclosing Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the agreement, securities sale, transaction value, or financial impacts provided in the available information. Sector not specified.
06-01-2026
Oncotelic Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000613, Size: 208 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided summary. Sector not specified.
06-01-2026
GLOBAL PARTNERS LP filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001335, size 369 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, nature of change (appointment or resignation), reasons, or compensation provided in the available information. Sector not specified.
06-01-2026
United Parks & Resorts Inc. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0001193125-26-004574, Size: 141 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or other quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Flowers Foods Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004576, Size: 176 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event type is Officer Change from US SEC source.
06-01-2026
Powell Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000080420-26-000009, Size: 141 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Middleby Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004740, size 160 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.
06-01-2026
STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004699, size 141 KB), disclosing under Item 1.02 the termination of a material definitive agreement and under Item 5.07 the submission of matters to a vote of security holders. No details on the agreement, vote outcomes, dollar values, or financial impacts are provided in the summary. Sector not specified.
06-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000619, Size: 225 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), along with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, parties, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.
06-01-2026
Celanese Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001306830-26-000003, Size: 256 KB), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or certain officers, and compensatory arrangements. Item 9.01 lists financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary.
06-01-2026
Skyward Specialty Insurance Group, Inc. filed an 8-K on 2026-01-06 (AccNo: 0001519449-26-000002, Size: 3 MB) announcing Item 1.01 Entry into a Material Definitive Agreement, Item 2.01 Completion of Acquisition or Disposition of Assets, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This indicates completion of a merger/acquisition event, but all specific deal structure, parties, valuation, consideration, synergies, regulatory details, and financial impacts are NOT_DISCLOSED.
06-01-2026
Investar Holding Corp filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000650, Size: 183 KB), disclosing completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), departure/election of directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific parties, transaction value, deal structure, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Neuronetics, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-004728, Size: 133 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the officer's name, position, nature of change (appointment/resignation), reasons, or compensation are NOT_DISCLOSED. Sector is not specified.
06-01-2026
Berkshire Hathaway Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004727, Size: 237 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data provided in the filing summary. Sector not specified.
06-01-2026
Instil Bio, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001789769-26-000004, Size: 146 KB) disclosing under Item 1.02 the termination of a material definitive agreement. Sector not specified. No details on the agreement counterparties, value, financial impacts, or strategic rationale provided.
06-01-2026
CareView Communications Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000653, Size: 316 KB) reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No details on transaction parties, value, terms, or financial metrics are disclosed in the provided summary. Sector not specified.
06-01-2026
Murphy Oil Corp filed a Form 8-K on January 6, 2026 (AccNo: 0000950103-26-000187, size 12 MB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source, but specific details on transactions, financial metrics, dollar values, or impacts are NOT_DISCLOSED. Sector is not specified.
06-01-2026
AMERICAN INTERNATIONAL GROUP, INC. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0000005272-26-000006, Size: 211 KB). Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits; no specific details on positions, reasons, or names provided.
06-01-2026
COMMUNITY FINANCIAL SYSTEM, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001402, size 203 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or individuals are provided. Sector is not specified.
06-01-2026
Safe & Green Development Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001868, Size: 483 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided information.
06-01-2026
OneStream, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004772, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details, transaction values, or financial metrics disclosed in the provided information. Sector not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 90 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC